Citadel Advisors’s TrovaGene, Inc. Warrant TROVW Stock Holding History

Citadel Advisors’s Portfolio TROVW Stock Details TROVW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-18,000	Closed	-$84K	–	7815
2016 Q1	$84K	Buy	18,000 +5,300	+42%	+$17.2K	﹤0.01%	6096
2015 Q4	$69K	Buy	+12,700	New	+$43.7K	﹤0.01%	7057
2015 Q3	–	Sell	-2,800	Closed	-$28K	–	9483
2015 Q2	$28K	Buy	+2,800	New	+$17.9K	﹤0.01%	8007

Other funds holding TROVW

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors's TROVW Position: Q3 2015 in Review

Citadel Advisors sold out of TrovaGene, Inc. Warrant (TROVW) in Q3 2015, closing a stake of 200 shares — an estimated $1K sold.

Citadel Advisors first reported a position in TROVW in Q2 2015 and held it in 1 quarter. The position peaked at $1K in Q2 2015. 3 funds tracked by Wall St. Rank hold TROVW as of Q3 2015.

Citadel Advisors reported no remaining TrovaGene, Inc. Warrant position as of Q3 2015 after selling out during the quarter.
Citadel Advisors sold 200 TrovaGene, Inc. Warrant shares in Q3 2015, an estimated $1K.
Citadel Advisors first reported a position in TrovaGene, Inc. Warrant in Q2 2015 and held it in 1 quarter.
Citadel Advisors's TrovaGene, Inc. Warrant position peaked at $1K in Q2 2015.
3 funds tracked by Wall St. Rank held TrovaGene, Inc. Warrant as of Q3 2015.

Based on Citadel Advisors's 13F filing for Q3 2015, filed 16 Nov 2015.